0 01/04/2023 31/03/2024 2024-03-31 false false false false false false false true false false true false false false false false false false No description of principal activities is disclosed 2023-04-01 Sage Accounts Production 23.0 - FRS102_2023 xbrli:pure xbrli:shares iso4217:GBP 00878347 2023-04-01 2024-03-31 00878347 2024-03-31 00878347 2023-03-31 00878347 2022-04-01 2023-03-31 00878347 2023-03-31 00878347 2022-03-31 00878347 bus:Director1 2023-04-01 2024-03-31 00878347 core:ShareCapital 2024-03-31 00878347 core:ShareCapital 2023-03-31 00878347 bus:SmallEntities 2023-04-01 2024-03-31 00878347 bus:AuditExempt-NoAccountantsReport 2023-04-01 2024-03-31 00878347 bus:SmallCompaniesRegimeForAccounts 2023-04-01 2024-03-31 00878347 bus:PrivateLimitedCompanyLtd 2023-04-01 2024-03-31 00878347 bus:FullAccounts 2023-04-01 2024-03-31
Company registration number: 00878347
Wyvern Organ Builders Limited
Unaudited filleted financial statements
31 March 2024
Wyvern Organ Builders Limited
Contents
Statement of financial position
Notes to the financial statements
Wyvern Organ Builders Limited
Statement of financial position
31 March 2024
2024 2023
Note £ £ £ £
Current assets
Debtors 4 8,000 8,000
_______ _______
8,000 8,000
Net current assets 8,000 8,000
_______ _______
Total assets less current liabilities 8,000 8,000
_______ _______
Net assets 8,000 8,000
_______ _______
Capital and reserves
Called up share capital 8,000 8,000
_______ _______
Shareholders funds 8,000 8,000
_______ _______
For the year ending 31 March 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476;
- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the statement of income and retained earnings has not been delivered.
These financial statements were approved by the board of directors and authorised for issue on 25 September 2024 , and are signed on behalf of the board by:
Mr G Lord
Director
Company registration number: 00878347
Wyvern Organ Builders Limited
Notes to the financial statements
Year ended 31 March 2024
1. General information
The company is a private company limited by shares, registered in Engalnd and Wales. The address of the registered office is Brooklands House, 58 Marlborough Road, Lancing, West Sussex, BN15 8AF.
2. Statement of compliance
These financial statements have been prepared in compliance with the provisions of FRS 102, Section 1A, 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The financial statements are prepared in sterling, which is the functional currency of the entity.
Taxation
The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in the statement of comprehensive income, except to the extent that it relates to items recognised in other comprehensive income or directly in capital and reserves. In this case, tax is recognised in other comprehensive income or directly in capital and reserves, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.
Financial instruments
A financial asset or a financial liability is recognised only when the company becomes a party to the contractual provisions of the instrument.
Basic financial instruments are initially recognised at the transaction price, unless the arrangement constitutes a financing transaction, where it is recognised at the present value of the future payments discounted at a market rate of interest for a similar debt instrument.
4. Debtors
2024 2023
£ £
Amounts owed by group undertakings 8,000 8,000
_______ _______
5. Controlling party
The company is under the control of Mr G Lord , by virtue of his controlling interest in the company's parent undertaking, Arthur Lord Organs Limited.